EUVIMEDEUVIMED entdecken
Crossref

Impact of CHA 2 DS 2 ‐VASc Score in the Outcomes of Patients Undergoing a Simplified Pathway for Percutaneous Left Atrial Appendage Closure

Claudio Sanfilippo iD, Marco Frazzetto iD, Giuliano Costa iD, Claudia Contrafatto, Chiara Giacalone, Francesco Briguglio, Chiara Barbera, Jessica De Santis, Maria Sanfilippo, Giuseppe Castania, Maria Elena Di Salvo, Salvatore Scandura und 6 weitere

Catheterization and Cardiovascular Interventions · 2025

DOI: 10.1002/ccd.31613 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Catheterization and Cardiovascular Interventions, 2025. Verfasst von Claudio Sanfilippo und 17 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Centro Cuore Morgagni, Catania, Italy. Hauptthemen laut MEDLINE: Atrial Appendage, Cardiac Catheterization, Atrial Fibrillation, Thromboembolism. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Percutaneous left atrial appendage closure (LAAC) is usually performed after a pre‐procedural evaluation by transesophageal echocardiography (TOE) or cardiac computed tomography angiography (CCTA). Nevertheless, these ad‐hoc examinations imply an additional use of hospital resources and time spending.

Aims

To investigate long‐term clinical outcomes, effectiveness and safety of performing LAAC procedures without pre‐procedural imaging assessment in patients with high and very high thromboembolic risk based on CHA 2 DS 2 ‐VASc score.

Methods

From January 2016 to January 2023, 227 consecutive patients undergoing LAAC following an optimized pathway that removed the use of pre‐procedural TOE or CCTA imaging assessment, were enrolled in this single‐center, retrospective study. Patients were divided into two groups based on thromboembolic risk: 94 had CHA 2 DS 2 ‐VASc scores ≥ 5 and 133 had CHA 2 DS 2 ‐VASc scores < 5). The primary endpoint was a composite of all‐cause death, stroke, systemic embolization, or bleeding events at 2 years. Co‐primary endpoints were device success, device‐related thrombosis (DRT) and peri‐device leaks (PDL) ≥ 3 mm at TOE follow‐up.

Results

At 2 years, no significant differences were observed between groups in the primary composite endpoint (KM est. 24.81% vs. 20.21%, p log‐rank = 0.7; aHR 0.85, CI: 0.48−1.50, p = 0.58). Device success was 98.7% overall, with no significant differences between groups (aOR 0.32% CI: 0.03−3.80; p = 0.37). DRT and PDL ≥ 3 mm rates were low (4.3% vs. 1.5%, p = 0.26% and 3.2% vs. 2.3%, p = 0.75, respectively). In‐hospital complications were low and comparable in both groups.

Conclusions

In a consecutive series of patients undergoing LAAC, a simplified approach without pre‐operative imaging assessment showed comparable results at 2‐year for the primary composite endpoint of all‐cause death, stroke, systemic embolization, or bleeding events in patients with CHA 2 DS 2 ‐VASc score ≥ 5 and those with CHA 2 DS 2 ‐VASc score < 5.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial AppendageCardiac CatheterizationAtrial FibrillationThromboembolismDecision Support TechniquesHumansRetrospective StudiesMaleFemaleAgedTreatment OutcomeRisk AssessmentRisk FactorsTime FactorsPredictive Value of TestsAged, 80 and overStrokeMiddle AgedLeft Atrial Appendage Closure

Stichwörter der Autor:innen

CHA2DS2‐Vasc scoreatrial fibrillation (AF)left atrial appendage closure (LAAC)pre‐procedural pathwaytransesophageal echocardiography (TOE)

Autor:innen und Institutionen

  • Division of Cardiology, Centro Cuore Morgagni, Catania, Italy.
  • School of Medicine, University Hospitals Harrington Heart & Vascular Institute, Case Western Reserve University, Cleveland, Ohio, USA.
  • Division of Cardiology, A.O.U. Policlinico "G. Rodolico San Marco", Catania, Italy.
  • Università degli Studi di Enna "Kore", Enna, Italy.

ORCID-Profile: Claudio Sanfilippo, Marco Frazzetto, Giuliano Costa, Guilherme Attizzani, Steven Filby

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Sanfilippo, C., Frazzetto, M., Costa, G., Contrafatto, C., Giacalone, C., Briguglio, F., Barbera, C., De Santis, J., Sanfilippo, M., Castania, G., Salvo, M. E. D., Scandura, S., Attizzani, G., Filby, S., Tamburino, C., Barbanti, M., Grasso, C., & Capodanno, D. (2025). Impact of CHA 2 DS 2 ‐VASc Score in the Outcomes of Patients Undergoing a Simplified Pathway for Percutaneous Left Atrial Appendage Closure. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31613

Vancouver

Sanfilippo C, Frazzetto M, Costa G, Contrafatto C, Giacalone C, Briguglio F, et al. Impact of CHA 2 DS 2 ‐VASc Score in the Outcomes of Patients Undergoing a Simplified Pathway for Percutaneous Left Atrial Appendage Closure. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.31613

BibTeX
@article{Sanfilippo2025,
  author = {Sanfilippo, Claudio and Frazzetto, Marco and Costa, Giuliano and Contrafatto, Claudia and Giacalone, Chiara and Briguglio, Francesco and Barbera, Chiara and De Santis, Jessica and Sanfilippo, Maria and Castania, Giuseppe and Salvo, Maria Elena Di and Scandura, Salvatore and Attizzani, Guilherme and Filby, Steven and Tamburino, Corrado and Barbanti, Marco and Grasso, Carmelo and Capodanno, Davide},
  title = {Impact of CHA 2 DS 2 ‐VASc Score in the Outcomes of Patients Undergoing a Simplified Pathway for Percutaneous Left Atrial Appendage Closure},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2025},
  doi = {10.1002/ccd.31613}
}
Kostenlos starten →